The best protocol for Ipamorelin and tirzepatide involves a phased approach: start tirzepatide at its lowest dose and titrate up over several weeks, then introduce daily Ipamorelin once tirzepatide is well-tolerated
Pre-treatment: Measure morning resting heart rate for 7 days Consider baseline ECG if not done recently Review all medications for cardiac interactions Discuss with physician specifically about the glucagon receptor heart rate effect During treatment: Measure resting heart rate daily during dose escalation Continue at each dose for minimum 6 to 8 weeks before increasing If resting HR exceeds baseline by more than 10 BPM, hold dose If resting HR exceeds 90 BPM at rest consistently, consult physician before any further increases Consider microdosing approach for ultra-gradual escalation Expected timeline: Weeks 1-12: very gradual heart rate change at low doses Weeks 12-30: moderate increase as dose slowly climbs Weeks 30+: stabilization (may occur later than standard protocol due to slower escalation) Protocol 3: monitoring-enhanced approach for data-driven researchers Who this is for: Researchers who want comprehensive data, athletes tracking performance metrics, anyone who finds data reassuring
Additional concerns include potential kidney problems in patients with existing kidney disease and acute kidney injury in severe dehydration cases
Others prefer smaller, more frequent meals to manage appetite and energy levels
If you are interested in exploring one of these options, please book an appointment to discuss with your doctor
Look for clear labeling (exact ingredient form, amount per serving, and lot tracking), third-party testing, and a company willing to share a certificate of analysis when asked (Mansilla WD, 2020)
